2016;4 [cited 2018 Aug 13]
The retrospective cohort study by Foer 2023 ( n = 1,642 patients with comorbid asthma or COPD receiving diabetes pharmacotherapy) demonstrated no significant excess respiratory exacerbation risk with GLP-1 RAs compared with DPP-4 inhibitors, SGLT2 inhibitors, or sulfonylureas [8]
Maintaining appropriate hydration is essential for patients taking GLP-1 medications, particularly given the common gastrointestinal side effects that can affect fluid balance
Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel diseases (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system
Extracted information included the following: first author, year of publication, country, study design, the total number of patients, types of AOX, duration of treatment in months, semen parameters (volume, total motility, progressive motility, concentration, and morphology), OS indices (TAC and MDA), SDF, and pregnancy-related outcomes (pregnancy rate, live-birth rate, and miscarriage rate)
